Algene Holding SE, a subsidiary of DN Group AG (ISIN: DE000A3DW408), has announced the first harvest of high-purity microalgae, achieving a total yield of 4,500 litres. This milestone signifies the start of series production after successful up-scaling, with the microalgae raw material intended for quality-critical products in the cosmetics and food industries, as well as potential pharmaceutical applications.
The Algene platform, developed in cooperation with the Technical University of Munich, enables controlled production of high-quality microalgae. Following the successful harvest, Algene has entered extensive talks with well-known companies from the cosmetics industry for purchase agreements. The initial delivery to a leading German cosmetics manufacturer is planned for the coming days, with the biomass primarily used for laboratory tests and validation of active ingredients.
The market for algae as a strategic resource for food and bio-based raw materials is growing dynamically. According to the EU Commission, the market in Europe alone is projected to grow to around 9 billion euros from 2030. Algae are considered a key component of the bioeconomy, and Algene Holding is positioning itself as an industrial platform for controlled microalgae production, targeting markets such as nutrition, food, cosmetics, life sciences, and aquaculture.
Ole Nixdorff, CEO of DN Group, stated: "For Algene, the start of series production is an important milestone. The market for microalgae is growing rapidly and offers enormous potential. The high level of interest underlines the high quality of the Algene material and the good market acceptance. As a shareholder in Algene, DN Group participates in this future market."
DN Group AG invests in impact companies with high growth opportunities in future industries such as AI, mobility, circular economy, food, health, and energy, supporting them in successful IPOs. The company is one of the leading providers of IPO and capital market transaction advice, connecting fast-growing ESG companies with international institutional investors. More information can be found on the company's website at www.dn-ag.com.
For investor and media relations, contact edicto GmbH at +49 69 90550 5-50 or via email at DN@edicto.de. The original press release is available at www.newmediawire.com.
